| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 331.570.434 $ | 67,07 | 16.619.785 | |||||||
| APOGEE THERAPEUTICS INC | APOGEE THERAPEUTICS INC | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 5.470.336 $ | 1,11 | 40.796 | |
| ORUKA THERAPEUTICS INC | ORUKA THERAPEUTICS INC | EC | 687604108 | Long | Börsenkurs (Stufe 1) | 5.086.077 $ | 1,03 | 52.700 | |
| DIANTHUS THERAPEUTICS INC | DIANTHUS THERAPEUTICS INC | EC | 252828108 | Long | Börsenkurs (Stufe 1) | 4.721.160 $ | 0,96 | 44.156 | |
| ERASCA INC | ERASCA INC | EC | 29479A108 | Long | Börsenkurs (Stufe 1) | 4.580.806 $ | 0,93 | 252.386 | |
| TWIST BIOSCIENCE CORP | Twist Bioscience Corporation COM USD0.00001 | EC | 90184D100 | Long | Börsenkurs (Stufe 1) | 4.558.366 $ | 0,92 | 49.791 | |
| KYMERA THERAPEUTICS INC | Kymera Therapeutics Inc COM | EC | 501575104 | Long | Börsenkurs (Stufe 1) | 4.459.952 $ | 0,90 | 43.133 | |
| SPYRE THERAPEUTICS INC | SPYRE THERAPEUTICS INC | EC | 00773J202 | Long | Börsenkurs (Stufe 1) | 4.419.147 $ | 0,89 | 44.942 | |
| REVOLUTION MEDICINES INC | Revolution Medicines Inc COM | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 4.388.577 $ | 0,89 | 23.402 | |
| CG ONCOLOGY INC | CG ONCOLOGY INC | EC | 156944100 | Long | Börsenkurs (Stufe 1) | 4.373.985 $ | 0,88 | 61.441 | |
| PROTAGONIST THERAPEUTICS INC | Protagonist Therapeutics Inc COM USD0.00001 | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 4.359.089 $ | 0,88 | 31.902 | |
| PRAXIS PRECISION MEDICINES INC | PRAXIS PRECISION MEDICINES I | EC | 74006W207 | Long | Börsenkurs (Stufe 1) | 4.315.777 $ | 0,87 | 14.020 | |
| REGENERON PHARMACEUTICALS INC | Regeneron Pharmaceuticals, Inc. COM USD0.001 | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 4.276.829 $ | 0,87 | 5.608 | |
| COGENT BIOSCIENCES INC | Cogent Biosciences Inc. COM | EC | 19240Q201 | Long | Börsenkurs (Stufe 1) | 4.186.260 $ | 0,85 | 107.533 | |
| NATERA INC | Natera Incorporation COM USD0.0001 | EC | 632307104 | Long | Börsenkurs (Stufe 1) | 4.173.843 $ | 0,84 | 15.588 | |
| ARROWHEAD PHARMACEUTICALS INC | Arrowhead Pharmaceuticals Inc COM USD0.001 | EC | 04280A100 | Long | Börsenkurs (Stufe 1) | 4.038.398 $ | 0,82 | 47.707 | |
| TRAVERE THERAPEUTICS INC | Travere Therapeutics Inc COM | EC | 89422G107 | Long | Börsenkurs (Stufe 1) | 4.035.034 $ | 0,82 | 72.196 | |
| ROIVANT SCIENCES LTD | ROIVANT SCIENCES LTD | EC | G76279101 | Long | Börsenkurs (Stufe 1) | 4.027.728 $ | 0,81 | 118.777 | |
| RELAY THERAPEUTICS INC | Relay Therapeutics Inc COM | EC | 75943R102 | Long | Börsenkurs (Stufe 1) | 4.023.237 $ | 0,81 | 213.661 | |
| MODERNA INC | Moderna Inc COM USD0.0001 | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 4.022.253 $ | 0,81 | 73.372 | |
| VAXCYTE INC | Vaxcyte Inc COM | EC | 92243G108 | Long | Börsenkurs (Stufe 1) | 4.017.820 $ | 0,81 | 74.294 | |
| BRIDGEBIO PHARMA INC | Bridgebio Pharma Inc COM USD0.001 | EC | 10806X102 | Long | Börsenkurs (Stufe 1) | 4.009.546 $ | 0,81 | 50.063 | |
| HALOZYME THERAPEUTICS INC | Halozyme Therapeutics Inc COM USD0.001 | EC | 40637H109 | Long | Börsenkurs (Stufe 1) | 3.950.612 $ | 0,80 | 47.863 | |
| RHYTHM PHARMACEUTICALS INC | Rhythm Pharmaceuticals Inc COM USD0.001 | EC | 76243J105 | Long | Börsenkurs (Stufe 1) | 3.907.473 $ | 0,79 | 39.370 | |
| CYTOKINETICS INC | Cytokinetics Inc COM USD0.001 | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 3.880.565 $ | 0,78 | 50.312 | |
| VIKING THERAPEUTICS INC | VIKING THERAPEUTICS INC | EC | 92686J106 | Long | Börsenkurs (Stufe 1) | 3.859.552 $ | 0,78 | 121.599 | |
| AMGEN INC | Amgen Inc. COM USD0.0001 | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 3.849.289 $ | 0,78 | 9.994 | |
| INCYTE CORP | Incyte Corporation. COM USD0.001 | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 3.826.791 $ | 0,77 | 32.018 | |
| MIRUM PHARMACEUTICALS INC | Mirum Pharmaceuticals Inc. COM USD0.0001 | EC | 604749101 | Long | Börsenkurs (Stufe 1) | 3.803.499 $ | 0,77 | 35.899 | |
| ALKERMES PLC | Alkermes PLC COM USD0.01 | EC | G01767105 | Long | Börsenkurs (Stufe 1) | 3.770.760 $ | 0,76 | 76.970 | |
| TG THERAPEUTICS INC | TG Therapeutics Inc COM USD0.001 | EC | 88322Q108 | Long | Börsenkurs (Stufe 1) | 3.765.931 $ | 0,76 | 72.380 | |
| ABBVIE INC | AbbVie Inc. COM USD0.01 | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 3.764.351 $ | 0,76 | 15.001 | |
| VERTEX PHARMACEUTICALS INC | Vertex Pharmaceuticals Incorporated COM USD0.01 | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 3.694.662 $ | 0,75 | 7.744 | |
| KRYSTAL BIOTECH INC | Krystal Biotech Inc COM USD0.00001 | EC | 501147102 | Long | Börsenkurs (Stufe 1) | 3.684.437 $ | 0,75 | 10.801 | |
| INSMED INC | Insmed Inc COM USD0.01 | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 3.621.184 $ | 0,73 | 36.726 | |
| SCHOLAR ROCK HOLDING CORP | SCHOLAR ROCK HOLDING CORP | EC | 80706P103 | Long | Börsenkurs (Stufe 1) | 3.619.676 $ | 0,73 | 76.534 | |
| GILEAD SCIENCES INC | Gilead Sciences, Inc. COM USD0.001 | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 3.617.234 $ | 0,73 | 27.780 | |
| BIOMARIN PHARMACEUTICAL INC | Biomarin Pharmaceutical Inc. COM USD0.001 | EC | 09061G101 | Long | Börsenkurs (Stufe 1) | 3.605.762 $ | 0,73 | 60.076 | |
| UNIQURE NV | UNIQURE NV | EC | N90064101 | Long | Börsenkurs (Stufe 1) | 3.543.498 $ | 0,72 | 81.217 | |
| DYNE THERAPEUTICS INC | DYNE THERAPEUTICS INC | EC | 26818M108 | Long | Börsenkurs (Stufe 1) | 3.542.977 $ | 0,72 | 140.706 | |
| BIOGEN INC | Biogen Inc COM USD0.0005 | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 3.525.242 $ | 0,71 | 17.370 | |
| NEUROCRINE BIOSCIENCES INC | Neurocrine Biosciences Inc COM USD0.001 | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 3.499.130 $ | 0,71 | 20.978 | |
| ACADIA PHARMACEUTICALS INC | Acadia Pharmaceuticals Inc COM USD0.0001 | EC | 004225108 | Long | Börsenkurs (Stufe 1) | 3.486.681 $ | 0,71 | 134.777 | |
| EXELIXIS INC | Exelixis, Inc. COM USD0.001 | EC | 30161Q104 | Long | Börsenkurs (Stufe 1) | 3.403.253 $ | 0,69 | 64.176 | |
| IMMUNOVANT INC | Immunovant Inc COM | EC | 45258J102 | Long | Börsenkurs (Stufe 1) | 3.372.221 $ | 0,68 | 87.318 | |
| MADRIGAL PHARMACEUTICALS INC | Madrigal Pharmaceuticals Inc USD0.0001 | EC | 558868105 | Long | Börsenkurs (Stufe 1) | 3.345.544 $ | 0,68 | 7.159 | |
| GRAIL INC | GRAIL INC | EC | 384747101 | Long | Börsenkurs (Stufe 1) | 3.311.996 $ | 0,67 | 48.308 | |
| CELCUITY INC | CELCUITY INC | EC | 15102K100 | Long | Börsenkurs (Stufe 1) | 3.303.258 $ | 0,67 | 38.241 | |
| SUMMIT THERAPEUTICS INC | SUMMIT THERAPEUTICS INC | EC | 86627T108 | Long | Börsenkurs (Stufe 1) | 3.288.670 $ | 0,67 | 252.586 | |
| CRISPR THERAPEUTICS AG | CRISPR Therapeutics AG COM CHF0.03 | EC | H17182108 | Long | Börsenkurs (Stufe 1) | 3.275.461 $ | 0,66 | 68.253 | |
| UNITED THERAPEUTICS CORP | United Therapeutics Corporation COM USD0.01 | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 3.210.837 $ | 0,65 | 6.202 | |
| PTC THERAPEUTICS INC | PTC Therapeutics, Inc. COM USD0.001 | EC | 69366J200 | Long | Börsenkurs (Stufe 1) | 3.128.868 $ | 0,63 | 46.006 | |
| ULTRAGENYX PHARMACEUTICAL INC | Ultragenyx Pharmaceuticals Inc COM USD0.001 | EC | 90400D108 | Long | Börsenkurs (Stufe 1) | 3.095.541 $ | 0,63 | 124.269 | |
| IMMUNITYBIO INC | IMMUNITYBIO INC | EC | 45256X103 | Long | Börsenkurs (Stufe 1) | 3.036.287 $ | 0,61 | 423.471 | |
| SELLAS LIFE SCIENCES GROUP INC | SELLAS LIFE SCIENCES GROUP I | EC | 81642T209 | Long | Börsenkurs (Stufe 1) | 2.935.433 $ | 0,59 | 293.250 | |
| BEAM THERAPEUTICS INC | Beam Therapeutics Incorporation COM | EC | 07373V105 | Long | Börsenkurs (Stufe 1) | 2.920.177 $ | 0,59 | 114.427 | |
| BIOCRYST PHARMACEUTICALS INC | BioCryst Pharmaceuticals Inc. COM USD0.01 | EC | 09058V103 | Long | Börsenkurs (Stufe 1) | 2.915.824 $ | 0,59 | 324.702 | |
| VERA THERAPEUTICS INC | VERA THERAPEUTICS INC | EC | 92337R101 | Long | Börsenkurs (Stufe 1) | 2.882.933 $ | 0,58 | 89.811 | |
| IDEAYA BIOSCIENCES INC | IDEAYA Biosciences Inc. COM USD0.0001 | EC | 45166A102 | Long | Börsenkurs (Stufe 1) | 2.783.839 $ | 0,56 | 78.418 | |
| DENALI THERAPEUTICS INC | Denali Therapeutics Inc COM USD0.01 | EC | 24823R105 | Long | Börsenkurs (Stufe 1) | 2.711.088 $ | 0,55 | 117.771 | |
| TANGO THERAPEUTICS INC | TANGO THERAPEUTICS INC | EC | 87583X109 | Long | Börsenkurs (Stufe 1) | 2.662.852 $ | 0,54 | 97.971 | |
| ARCUTIS BIOTHERAPEUTICS INC | ARCUTIS BIOTHERAPEUTICS INC | EC | 03969K108 | Long | Börsenkurs (Stufe 1) | 2.652.291 $ | 0,54 | 98.745 | |
| CELLDEX THERAPEUTICS INC | Celldex Therapeutics Inc. COM USD0.001(POST REV SPLT | EC | 15117B202 | Long | Börsenkurs (Stufe 1) | 2.612.591 $ | 0,53 | 68.644 | |
| VIRIDIAN THERAPEUTICS INC | Viridian Therapeutics Inc COM | EC | 92790C104 | Long | Börsenkurs (Stufe 1) | 2.515.168 $ | 0,51 | 132.937 | |
| DISC MEDICINE INC | DISC MEDICINE INC | EC | 254604101 | Long | Börsenkurs (Stufe 1) | 2.500.729 $ | 0,51 | 32.477 | |
| ARCUS BIOSCIENCES INC | Arcus Biosciences Inc. COM USD0.0001 | EC | 03969F109 | Long | Börsenkurs (Stufe 1) | 2.471.586 $ | 0,50 | 87.676 | |
| MINERALYS THERAPEUTICS INC | MINERALYS THERAPEUTICS INC | EC | 603170101 | Long | Börsenkurs (Stufe 1) | 2.439.151 $ | 0,49 | 95.578 | |
| IONIS PHARMACEUTICALS INC | Ionis Pharmaceuticals, Inc. COM USD0.001 | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 2.382.611 $ | 0,48 | 46.023 | |
| ALNYLAM PHARMACEUTICALS INC | Alnylam Pharmaceuticals Inc. COM USD0.01 | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 2.381.155 $ | 0,48 | 11.586 | |
| VERACYTE INC | Veracyte Inc COM USD0.001 | EC | 92337F107 | Long | Börsenkurs (Stufe 1) | 2.348.748 $ | 0,48 | 50.707 | |
| IMMUNOME INC | IMMUNOME INC | EC | 45257U108 | Long | Börsenkurs (Stufe 1) | 2.313.986 $ | 0,47 | 101.669 | |
| SYNDAX PHARMACEUTICALS INC | Syndax Pharmaceuticals Inc. COM USD0.0001 | EC | 87164F105 | Long | Börsenkurs (Stufe 1) | 2.277.199 $ | 0,46 | 119.538 | |
| RECURSION PHARMACEUTICALS INC | Recursion Pharmaceuticals Inc CL A | EC | 75629V104 | Long | Börsenkurs (Stufe 1) | 2.250.297 $ | 0,46 | 750.099 | |
| SAREPTA THERAPEUTICS INC | Sarepta Therapeutics Inc COM USD0.0001 | EC | 803607100 | Long | Börsenkurs (Stufe 1) | 2.246.193 $ | 0,45 | 151.157 | |
| ADMA BIOLOGICS INC | Adma Biologics Inc COM USD0.0001 | EC | 000899104 | Long | Börsenkurs (Stufe 1) | 2.233.812 $ | 0,45 | 264.044 | |
| KODIAK SCIENCES INC | KODIAK SCIENCES INC | EC | 50015M109 | Long | Börsenkurs (Stufe 1) | 2.112.597 $ | 0,43 | 50.808 | |
| INTELLIA THERAPEUTICS INC | Intellia Therapeutics Inc COM USD0.0001 | EC | 45826J105 | Long | Börsenkurs (Stufe 1) | 2.083.422 $ | 0,42 | 195.077 | |
| AGIOS PHARMACEUTICALS INC | Agios Pharmaceuticals Inc COM USD0.001 | EC | 00847X104 | Long | Börsenkurs (Stufe 1) | 2.039.709 $ | 0,41 | 67.945 | |
| IOVANCE BIOTHERAPEUTICS INC | Iovance Biotherapeutics Inc COM USD0.000041666 | EC | 462260100 | Long | Börsenkurs (Stufe 1) | 2.004.447 $ | 0,41 | 492.493 | |
| NURIX THERAPEUTICS INC | NURIX THERAPEUTICS INC | EC | 67080M103 | Long | Börsenkurs (Stufe 1) | 1.939.567 $ | 0,39 | 83.566 | |
| PALVELLA THERAPEUTICS INC | PALVELLA THERAPEUTICS INC | EC | 697947109 | Long | Börsenkurs (Stufe 1) | 1.930.848 $ | 0,39 | 13.887 | |
| NOVAVAX INC | NOVAVAX INC | EC | 670002401 | Long | Börsenkurs (Stufe 1) | 1.867.449 $ | 0,38 | 255.116 | |
| VERICEL CORP | Vericel Corporation COM NPV | EC | 92346J108 | Long | Börsenkurs (Stufe 1) | 1.865.103 $ | 0,38 | 40.581 | |
| BIOHAVEN LTD | Biohaven Ltd COM NPV | EC | G1110E107 | Long | Börsenkurs (Stufe 1) | 1.738.989 $ | 0,35 | 128.814 | |
| CAREDX INC | Caredx Inc COM USD0.001 | EC | 14167L103 | Long | Börsenkurs (Stufe 1) | 1.698.177 $ | 0,34 | 38.851 | |
| STOKE THERAPEUTICS INC | STOKE THERAPEUTICS INC | EC | 86150R107 | Long | Börsenkurs (Stufe 1) | 1.543.202 $ | 0,31 | 53.472 | |
| PRECIGEN INC | PRECIGEN INC | EC | 74017N105 | Long | Börsenkurs (Stufe 1) | 1.509.584 $ | 0,31 | 240.763 | |
| TYRA BIOSCIENCES INC | TYRA BIOSCIENCES INC | EC | 90240B106 | Long | Börsenkurs (Stufe 1) | 1.508.307 $ | 0,31 | 47.312 | |
| VIR BIOTECHNOLOGY INC | VIR Biotechnology Inc COM | EC | 92764N102 | Long | Börsenkurs (Stufe 1) | 1.455.296 $ | 0,29 | 168.048 | |
| ZENAS BIOPHARMA INC | ZENAS BIOPHARMA INC | EC | 98937L105 | Long | Börsenkurs (Stufe 1) | 1.441.681 $ | 0,29 | 45.855 | |
| ANAPTYSBIO INC | ANAPTYSBIO INC | EC | 032724106 | Long | Börsenkurs (Stufe 1) | 1.426.206 $ | 0,29 | 26.728 | |
| FIRST TRACKS BIOTHERAPEUTICS INC | FIRST TRACKS BIOTHERAPEUTICS | EC | 337185102 | Long | Börsenkurs (Stufe 1) | 1.392.325 $ | 0,28 | 31.615 | |
| ABSCI CORP | ABSCI CORP | EC | 00091E109 | Long | Börsenkurs (Stufe 1) | 1.367.117 $ | 0,28 | 175.722 | |
| HYPERLIQUID STRATEGIES INC | HYPERLIQUID STRATEGIES | EC | 44916Y106 | Long | Börsenkurs (Stufe 1) | 1.335.628 $ | 0,27 | 215.077 | |
| CULLINAN THERAPEUTICS INC | CULLINAN ONCOLOGY INC | EC | 230031106 | Long | Börsenkurs (Stufe 1) | 1.333.052 $ | 0,27 | 80.791 | |
| XENCOR INC | Xencor Inc COM USD0.01 | EC | 98401F105 | Long | Börsenkurs (Stufe 1) | 1.332.082 $ | 0,27 | 65.912 | |
| CORVUS PHARMACEUTICALS INC | CORVUS PHARMACEUTICALS INC | EC | 221015100 | Long | Börsenkurs (Stufe 1) | 1.320.921 $ | 0,27 | 99.617 | |
| VOR BIOPHARMA INC | VOR BIOPHARMA INC | EC | 929033207 | Long | Börsenkurs (Stufe 1) | 1.262.126 $ | 0,26 | 59.675 | |
| AVALO THERAPEUTICS INC | AVALO THERAPEUTICS INC | EC | 05338F306 | Long | Börsenkurs (Stufe 1) | 1.258.484 $ | 0,25 | 68.958 | |
| ARDELYX INC | ARDELYX INC | EC | 039697107 | Long | Börsenkurs (Stufe 1) | 1.247.519 $ | 0,25 | 252.024 | |
| ORIC PHARMACEUTICALS INC | ORIC PHARMACEUTICALS INC | EC | 68622P109 | Long | Börsenkurs (Stufe 1) | 1.228.250 $ | 0,25 | 110.953 | |
| MONTE ROSA THERAPEUTICS INC | MONTE ROSA THERAPEUTICS INC | EC | 61225M102 | Long | Börsenkurs (Stufe 1) | 1.186.516 $ | 0,24 | 71.823 | |
| MANNKIND CORP | Mannkind Corporation COM USD0.01 | EC | 56400P706 | Long | Börsenkurs (Stufe 1) | 1.131.679 $ | 0,23 | 289.432 | |
| INHIBRX BIOSCIENCES INC | INHIBRX BIOSCIENCES INC | EC | 45720N103 | Long | Börsenkurs (Stufe 1) | 1.118.095 $ | 0,23 | 13.627 | |
| TAYSHA GENE THERAPIES INC | TAYSHA GENE THERAPIES INC | EC | 877619106 | Long | Börsenkurs (Stufe 1) | 1.108.226 $ | 0,22 | 189.117 | |
| ANNEXON INC | ANNEXON INC | EC | 03589W102 | Long | Börsenkurs (Stufe 1) | 1.079.248 $ | 0,22 | 211.825 | |
| OLEMA PHARMACEUTICALS INC | OLEMA PHARMACEUTICALS INC | EC | 68062P106 | Long | Börsenkurs (Stufe 1) | 1.057.087 $ | 0,21 | 92.322 | |
| REPLIMUNE GROUP INC | REPLIMUNE GROUP INC | EC | 76029N106 | Long | Börsenkurs (Stufe 1) | 1.045.296 $ | 0,21 | 93.330 | |
| SIONNA THERAPEUTICS INC | SIONNA THERAPEUTICS INC | EC | 829401108 | Long | Börsenkurs (Stufe 1) | 1.037.284 $ | 0,21 | 22.009 | |
| JADE BIOSCIENCES INC | JADE BIOSCIENCES INC | EC | 008064206 | Long | Börsenkurs (Stufe 1) | 1.029.232 $ | 0,21 | 52.113 | |
| BICARA THERAPEUTICS INC | BICARA THERAPEUTICS INC | EC | 055477103 | Long | Börsenkurs (Stufe 1) | 1.009.773 $ | 0,20 | 37.261 | |
| JANUX THERAPEUTICS INC | JANUX THERAPEUTICS INC | EC | 47103J105 | Long | Börsenkurs (Stufe 1) | 994.075 $ | 0,20 | 65.529 | |
| GERON CORP | Geron Corp. COM USD0.001 | EC | 374163103 | Long | Börsenkurs (Stufe 1) | 956.317 $ | 0,19 | 741.331 | |
| KURA ONCOLOGY INC | Kura Oncology Incorporation COM USD0.0001 | EC | 50127T109 | Long | Börsenkurs (Stufe 1) | 941.536 $ | 0,19 | 104.499 | |
| ARRIVENT BIOPHARMA INC | ARRIVENT BIOPHARMA INC | EC | 04272N102 | Long | Börsenkurs (Stufe 1) | 888.725 $ | 0,18 | 29.803 | |
| CYTOMX THERAPEUTICS INC | CYTOMX THERAPEUTICS INC | EC | 23284F105 | Long | Börsenkurs (Stufe 1) | 838.913 $ | 0,17 | 270.617 | |
| RIGEL PHARMACEUTICALS INC | RIGEL PHARMACEUTICALS INC | EC | 766559702 | Long | Börsenkurs (Stufe 1) | 813.243 $ | 0,16 | 22.093 | |
| IRONWOOD PHARMACEUTICALS INC | IRONWOOD PHARMACEUTICALS INC | EC | 46333X108 | Long | Börsenkurs (Stufe 1) | 790.528 $ | 0,16 | 186.886 | |
| ALTIMMUNE INC | ALTIMMUNE INC | EC | 02155H200 | Long | Börsenkurs (Stufe 1) | 781.349 $ | 0,16 | 275.123 | |
| ALLOGENE THERAPEUTICS INC | ALLOGENE THERAPEUTICS INC | EC | 019770106 | Long | Börsenkurs (Stufe 1) | 775.716 $ | 0,16 | 412.615 | |
| SANA BIOTECHNOLOGY INC | SANA BIOTECHNOLOGY INC | EC | 799566104 | Long | Börsenkurs (Stufe 1) | 752.743 $ | 0,15 | 240.493 | |
| SOLID BIOSCIENCES INC | SOLID BIOSCIENCES INC | EC | 83422E204 | Long | Börsenkurs (Stufe 1) | 707.241 $ | 0,14 | 87.747 | |
| DAMORA THERAPEUTICS INC | DAMORA THERAPEUTICS INC | EC | G2646Y104 | Long | Börsenkurs (Stufe 1) | 704.254 $ | 0,14 | 24.293 | |
| CANDEL THERAPEUTICS INC | CANDEL THERAPEUTICS INC | EC | 137404109 | Long | Börsenkurs (Stufe 1) | 688.408 $ | 0,14 | 68.772 | |
| VERASTEM INC | VERASTEM INC | EC | 92337C203 | Long | Börsenkurs (Stufe 1) | 667.911 $ | 0,14 | 115.157 | |
| REGENXBIO INC | REGENXBIO INC | EC | 75901B107 | Long | Börsenkurs (Stufe 1) | 644.966 $ | 0,13 | 66.560 | |
| IMMIX BIOPHARMA INC | IMMIX BIOPHARMA INC | EC | 45258H106 | Long | Börsenkurs (Stufe 1) | 594.838 $ | 0,12 | 71.495 | |
| SAVARA INC | SAVARA INC | EC | 805111101 | Long | Börsenkurs (Stufe 1) | 592.967 $ | 0,12 | 108.602 | |
| OCUGEN INC | OCUGEN INC | EC | 67577C105 | Long | Börsenkurs (Stufe 1) | 584.561 $ | 0,12 | 475.253 | |
| 4D MOLECULAR THERAPEUTICS INC | 4D MOLECULAR THERAPEUTICS IN | EC | 35104E100 | Long | Börsenkurs (Stufe 1) | 556.449 $ | 0,11 | 54.661 | |
| ARBUTUS BIOPHARMA CORP | ARBUTUS BIOPHARMA CORP | EC | 03879J100 | Long | Börsenkurs (Stufe 1) | 542.049 $ | 0,11 | 124.896 | |
| PRIME MEDICINE INC | PRIME MEDICINE INC | EC | 74168J101 | Long | Börsenkurs (Stufe 1) | 518.557 $ | 0,10 | 177.588 | |
| CABALETTA BIO INC | CABALETTA BIO INC | EC | 12674W109 | Long | Börsenkurs (Stufe 1) | 478.664 $ | 0,10 | 178.606 | |
| COMPASS THERAPEUTICS INC | COMPASS THERAPEUTICS INC | EC | 20454B104 | Long | Börsenkurs (Stufe 1) | 443.909 $ | 0,09 | 232.413 | |
| EMERGENT BIOSOLUTIONS INC | EMERGENT BIOSOLUTIONS INC | EC | 29089Q105 | Long | Börsenkurs (Stufe 1) | 418.601 $ | 0,08 | 57.978 | |
| MIMEDX GROUP INC | MiMedx Group Inc. COM USD0.001 | EC | 602496101 | Long | Börsenkurs (Stufe 1) | 414.962 $ | 0,08 | 100.475 | |
| PROTHENA CORP PLC | PROTHENA CORP PLC | EC | G72800108 | Long | Börsenkurs (Stufe 1) | 401.006 $ | 0,08 | 49.385 | |
| PERSPECTIVE THERAPEUTICS INC | PERSPECTIVE THERAPEUTICS INC | EC | 46489V302 | Long | Börsenkurs (Stufe 1) | 399.112 $ | 0,08 | 137.152 | |
| ARS PHARMACEUTICALS INC | ARS PHARMACEUTICALS INC | EC | 82835W108 | Long | Börsenkurs (Stufe 1) | 398.673 $ | 0,08 | 77.714 | |
| VANDA PHARMACEUTICALS INC | VANDA PHARMACEUTICALS INC | EC | 921659108 | Long | Börsenkurs (Stufe 1) | 397.147 $ | 0,08 | 77.872 | |
| OVID THERAPEUTICS INC | OVID THERAPEUTICS INC | EC | 690469101 | Long | Börsenkurs (Stufe 1) | 371.182 $ | 0,08 | 167.199 | |
| LEXEO THERAPEUTICS INC | LEXEO THERAPEUTICS INC | EC | 52886X107 | Long | Börsenkurs (Stufe 1) | 340.956 $ | 0,07 | 82.556 | |
| ACHIEVE LIFE SCIENCES INC | ACHIEVE LIFE SCIENCES INC | EC | 004468500 | Long | Börsenkurs (Stufe 1) | 294.453 $ | 0,06 | 45.865 | |
| MYRIAD GENETICS INC | Myriad Genetics Inc. COM USD0.01 | EC | 62855J104 | Long | Börsenkurs (Stufe 1) | 293.058 $ | 0,06 | 102.468 | |
| CAPRICOR THERAPEUTICS INC | CAPRICOR THERAPEUTICS INC | EC | 14070B309 | Long | Börsenkurs (Stufe 1) | 284.145 $ | 0,06 | 73.804 | |
| SAGIMET BIOSCIENCES INC | SAGIMET BIOSCIENCES INC-A | EC | 786700104 | Long | Börsenkurs (Stufe 1) | 237.495 $ | 0,05 | 33.403 | |
| BRIDGEBIO ONCOLOGY THERAPEUTICS INC | BRIDGEBIO ONCOLOGY THERAPEUT | EC | 107924102 | Long | Börsenkurs (Stufe 1) | 223.559 $ | 0,05 | 27.634 | |
| MAPLIGHT THERAPEUTICS INC | MAPLIGHT THERAPEUTICS INC | EC | 56565P103 | Long | Börsenkurs (Stufe 1) | 220.520 $ | 0,04 | 16.937 | |
| NOVOB DC CVR | NOVOB DC CVR | EC | 009CVR044 | Long | Börsenkurs (Stufe 1) | 0 $ | 0,00 | 128.720 | |
| VERVE THERAPEUTICS INC (CVR) | VERVE THERAPEUTICS INC (CVR) | EC | 925CVR011 | Long | Börsenkurs (Stufe 1) | 0 $ | 0,00 | 82.531 | |
| OMNIAB INC | OmniAb Inc. USD0.0001 A (USD12.5 VESTING) | EC | 68218J202 | Long | Börsenkurs (Stufe 1) | 0 $ | 0,00 | 29.566 | |
| INHIBRX INC CVR | INHIBRX INC CVR | EC | 457CVR017 | Long | Börsenkurs (Stufe 1) | 0 $ | 0,00 | 164.173 | |
| 331.570.434 $ | 67,07 | 16.619.785 |
Keine Anlageberatung, keine individuelle Empfehlung.
Die hier gezeigten Zahlen sind eine aggregierte Auswertung öffentlich zugänglicher
aufsichtsrechtlicher Pflichtmeldungen und öffentlicher Register und stellen keine
Bewertung oder Empfehlung zu einzelnen Wertpapieren, Fonds oder Emittenten dar.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in genannten Werten halten. Methodik: Berechnungsgrundlagen.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in genannten Werten halten. Methodik: Berechnungsgrundlagen.
Keine Anlageberatung, keine individuelle Empfehlung.
Aggregierte Auswertung öffentlicher Pflichtmeldungen, keine Bewertung einzelner
Wertpapiere. Der Betreiber kann über verlinkte Anbieter Affiliate-Vergütungen
erhalten und ggf. eigene Positionen halten.
Rechtliche Hinweise.